+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dementia Drug"

Neurodegenerative Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Lewy Body Dementia Global Market Report 2025 - Product Thumbnail Image

Lewy Body Dementia Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Frontotemporal Dementia Market - Global Strategic Business Report - Product Thumbnail Image

Frontotemporal Dementia Market - Global Strategic Business Report

  • Report
  • December 2025
  • 381 Pages
  • Global
From
From
From
Dementia Treatment Market - Product Thumbnail Image

Dementia Treatment Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Dementia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Dementia drugs are used to treat the cognitive decline associated with Alzheimer's disease, vascular dementia, and other forms of dementia. These drugs are typically prescribed to improve memory, thinking, and behavior, as well as to slow the progression of the disease. Common dementia drugs include cholinesterase inhibitors, memantine, and glutamate modulators. Some companies in the Dementia Drug market include Pfizer, Novartis, Merck, and Eli Lilly. Other companies include Biogen, AstraZeneca, and Johnson & Johnson. Show Less Read more